Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,223 INR | -0.38% | -0.02% | +12.61% |
May. 27 | Aurobindo Pharma Clocks Gains in Fiscal Q4 Consolidated Net Profit | MT |
May. 27 | Transcript : Aurobindo Pharma Limited, Q4 2024 Earnings Call, May 27, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.61% | 8.65B | |
+42.60% | 748B | |
+32.34% | 598B | |
-5.74% | 356B | |
+17.79% | 325B | |
+3.37% | 283B | |
+16.47% | 245B | |
+9.26% | 211B | |
-5.07% | 209B | |
+6.74% | 165B |
- Stock Market
- Equities
- AUROPHARMA Stock
- News Aurobindo Pharma
- Aurobindo Pharma Ltd Appoints P. Sarath Chandra Reddy as Wholetime Director, Effective from June 01, 2016